STAT News
STAT+: OpenEvidence backs study that finds it beats LLMs
In this edition of STAT Health Tech: Dueling research pitting OpenEvidence against general purpose LLMs, use of Dexcom's CGM in children, and more.
NASA·USGS·WHO 등 과학·연구·보건 기관의 공식 자료. Public Domain / WHO 라이선스로 본문 직접 표시.
총 361건
In this edition of STAT Health Tech: Dueling research pitting OpenEvidence against general purpose LLMs, use of Dexcom's CGM in children, and more.
RFK Jr.'s list of Covid vaccine injuries, a father's quest to cure his daughter, and more health news from Morning Rounds
Two years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain cancer treatment for regulatory approval.
AstraZeneca and Ionis reported a notable trial failure Thursday in a heart disease that's become an increasingly competitive market for drugmakers.
Over the past 25 years, I have treated thousands of medical cannabis patients with extremely few ill effects, one doctor writes.
“The new wave of obesity pharmacotherapy has leaned heavily on disease framing,” writes Max Moser, drawing comparisons to the antidepressant revolution.
How a father’s quest may shape the future of rare disease gene therapy.
STAT's Alex Hogan and Chelsea Cirruzzo stopped by "MAHA Monday" at the Great American State Fair. Watch their report in this week's STATus Report.
It's not clear what conditions may make the list, but outside experts are watching it closely.
The White House is reviewing finalists, suggesting the highly anticipated decision may come soon.
The Brigham, a nationally renowned Harvard teaching hospital, and MGB have have unsuccessfully been negotiating a new contract for months.
Marco Rubio, RFK Jr., and Chris Klomp are urging industry leaders to make more medicines in the U.S.
Why longevity entrepreneur Bryan Johnson’s chronic disease is notoriously difficult to diagnose.
For the second year in a row, many Affordable Care Act insurers are proposing double-digit premium increases, driven by rising medical costs as well as federal policy changes.
Lung cancer patients hadn't been seen as candidates for organ transplant. Now a study finds patients did well.
Kailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech news from The Readout
Prime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene-editing companies against each other.
The FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathy
FDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning Rounds
Three tricky questions about using AI in dementia care.